BioWorld Launches Enhanced Biopharma News Site with Data, Analysis
ATLANTA, Aug. 22, 2012 /PRNewswire-USNewswire/ -- Biopharmaceutical industry insiders know that news about the world's most innovative drugs in development has always come from BioWorld. BioWorld's award-winning coverage of the biopharma industry continues, but now it's even better with an enhanced website (www.bioworld.com).
Biotech news junkies have a reason to make BioWorld.com their home page. Visit in the morning to get a daily biopharma news fix. Then stay for breaking news as it happens plus analysis, opinion and much more.
Last fall, BioWorld implemented phase I enhancements including a turbo-charged search engine, breaking news bulletins, one-click access to the biopharma social community and a brand new blog.
With phase II, subscribers can dig deeper into new portals that group popular news topics in these Latest News sections: U.S., Europe, In the Clinic, Deals and M&A, Financings, NewCo News and Regulatory.
"Science fans have a dedicated portal too, dubbed The BioWorld Biome: Our Habitat for All Things Science," said Lynn Yoffee , BioWorld's executive editor. " And for those who think BioWorld is just about breaking news, we bring BioWorld Insight and BioWorld Snapshots front and center with Analysis and Data features, taking a deeper dive into trends, impact and commentary on the biotech market."
BioWorld Snapshots explore key trends and data including:
- Public Offerings
- Private Offerings, Mergers & Acquisitions
- Biotech & Pharma Collaborations, Biotech & Biotech Collaborations
- Products on the Market, and Biotech Market Capitalization.
BioWorld Today, and its analytical companion, BioWorld Insight, are the biopharmaceutical industry's most respected news sources for more than two decades. To subscribe, call (800) 477-6307 or, outside the U.S., (404) 262-5476 or visit www.bioworld.com.
Contact: Lynn Yoffee
More by this Source
In Q1 Public Biopharmas Shift Fundraising into Overdrive
Apr 08, 2013, 11:23 ET
Recall of Anemia Drug Omontys Rings Alarm Over Biosimilars
Feb 27, 2013, 11:57 ET
Tsunami of Coming Biosimilars Set to Shake up Drug Development Game
Jan 24, 2013, 09:49 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.